Tauranga Skin Cancer Clinic

Details Doctors
Medical Suppliers In Bay of Plenty

Name :

Tauranga Skin Cancer Clinic

Address  :

19 Second Avenue

Town  :

Tauranga

State  :

Bay of Plenty

Country  :

NEW ZEALAND

Post Code:

3110

Phone  :

07 578 8089

Fax  :

07 878 8090

Web URL  :

Available

Email  :

info@skin-cancer-clinic.co.nz
Specialization
  • Dermatology
  • Oncologist
Facilities
Information not available, if you are owner/employee of Tauranga Skin Cancer Clinic Please click to update hospital details.
Description
About The Clinic
Our Clinic provides general practice based skin cancer care Dr Strydom the founder of the clinic has been credentialed by the DHB and PHO to provide basic to advanced level of care for patients with skin cancer This means the clinic can provide screening ranging from basic skin checks to advanced Dermoscopy evaluation of skin lesions Treatment includes topical treatment to surgical procedures Despite being known as quot The Capital of skin Cancerquot Screening is not funded by the government

Surgical procedures range from basic skin biopsies to advanced skin grafts and skin flaps quotOur main concern is to find the most appropriate form of treatment for the specific form of skin cancer and treatment that is best suited to each individual patient With our purpose built Operating Theatre we can deliver a wide range of surgical interventionsquot The Clinic is situated within City Centre Medical in 2nd Ave Tauranga
NEWS
New Zealand Hospitals Face Staff Shortage

A Nurses Organization survey was carried out in New Zealand which has revealed that there is a need of nearly 120 nurses at the hospital wards It is being claimed by working nurses that the nursepatient ratio affects their capability of undertaking the job As per the findings the ratio causes them to provide only basic care to patients which in ... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More